Biotech founder counters the skeptics with anti-aging program

Bill Andrews has been featured in Popular Science and interviewed on "The Today Show," but he can still see eyes start to roll when he starts talking about his research on a new anti-aging treatment. "Quacks and charlatans have done a great job of discrediting the field of anti-aging for thousands of years," says Andrews, a veteran of Geron, in an interview with the Reno Gazette-Journal. "Nowadays, science has come a long way. But it's really hard to approach investors and have them listen to you for more than 5 seconds after they hear you're doing research on anti-aging." Report

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.